NBIX vs VRA · P/E 45, rev $1.77B vs rev $84.9M
Neurocrine Biosciences Inc (NBIX) versus Vera Bradley Inc (VRA) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Vera Bradley Inc (VRA) is a footwear & accessories company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported VRA revenue for 2026-01-31 was $84.9M. Net income was $2.7M. Revenue was down 77.2% from 2025-02-01 to 2026-01-31. VRA currently screens at market cap $107.2M.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. VRA currently screens at market cap $107.2M.
Not investment advice. Open the NBIX and VRA stock pages for the full models.
Not investment advice.